$INSM News

Guggenheim Reiterates Buy on Insmed, Maintains $207 Price Target

Insmed Appoints Samuele Butera as Senior Vice President, General Manager, Global Respiratory

Should Insmed’s (INSM) NASDAQ-100 Exit and TPIP Focus Require Action From Investors?

Is Insmed (INSM) One of the Most Promising Healthcare Stocks After Cantor Fitzgerald’s Target Raise?

Evercore ISI Group Maintains Outperform on Insmed, Lowers Price Target to $160

Insmed Incorporated (INSM) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

Is Insmed (INSM) The Best Healthcare Stock to Buy Now?

JP Morgan Maintains Overweight on Insmed, Lowers Price Target to $179

Is Insmed's (INSM) Brensocatib Momentum Quietly Reframing Its Respiratory Growth Narrative?

Insmed Brinsupri Shows Strong Physician Conviction, Early Launch Momentum, RBC Says

RBC Capital Maintains Outperform on Insmed, Lowers Price Target to $195

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

A Look At Insmed (INSM) Valuation After Recent Share Price Weakness And Brensocatib Launch Expectations

ATS 2026: Insmed shines in bronchiectasis with spotlight on Brinsupri

Insmed Incorporated (INSM) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript

Assessing Insmed (INSM) Valuation After Recent Share Price Pullback And Strong Multi Year Returns

Insmed CEO Defends BRINSUPRI Launch as Sales Surge, TPIP Pipeline Gains Focus

Insmed Files For Mixed Shelf Offering; Size Not Disclosed

Truist Securities Maintains Buy on Insmed, Lowers Price Target to $185

Insmed Incorporated (INSM) Reports Q1 2026 Results